PTCT Jun 2024 29.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:09PM EDT. Market open.
| Previous close | 3.6000 |
| Open | N/A |
| Bid | 3.0000 |
| Ask | 5.5000 |
| Strike | 29.00 |
| Expiry date | 2024-06-21 |
| Day's range | 3.6000 - 3.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 5 |
GuruFocus.comInsider Sale: Director Jerome Zeldis Sells 20,000 Shares of PTC Therapeutics Inc (PTCT)
Director Jerome Zeldis of PTC Therapeutics Inc (NASDAQ:PTCT) executed a sale of 20,000 shares of the company on May 22, 2024, according to a recent SEC Filing.
ZacksThe Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics
Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics are part of the Zacks top Analyst Blog.
ZacksBiotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Biogen (BIIB) and PTC Therapeutics, Inc. (PTCT) are in the spotlight following acquisition news and regulatory updates, respectively.
© 2024 Yahoo. All rights reserved.